Cargando…
Identification of cancer/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis
The 5-year survival rate of hepatocellular carcinoma (HCC) is <20%; thus, identifying new potential therapeutic targets or novel biomarkers for prognosis prediction is crucial. The present study aimed to screen hub genes by constructing protein-protein interaction (PPI) subnetworks using topologi...
Autores principales: | Liu, Jinwei, Yu, Zhaojin, Sun, Mingli, Liu, Qianqian, Wei, Minjie, Gao, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781590/ https://www.ncbi.nlm.nih.gov/pubmed/31611988 http://dx.doi.org/10.3892/ol.2019.10811 |
Ejemplares similares
-
Designing high affinity target-binding peptides to HLA-E: a key membrane antigen of multiple myeloma
por: Yang, Ying, et al.
Publicado: (2020) -
Identification of hub subnetwork based on topological features of genes in breast cancer
por: ZHUANG, DA-YONG, et al.
Publicado: (2015) -
Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy
por: Liu, Jun, et al.
Publicado: (2016) -
Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma
por: Xu, Yingyu, et al.
Publicado: (2023) -
Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia
por: Zhu, Yingqian, et al.
Publicado: (2023)